High-fat diet based on trienantin has no adverse metabolic effects in rats

European Journal of Lipid Science and Technology

Volumn 112, Issue 2, 2010, Pages 166-172

  de Melo Lucena, Ana L ^a   de Oliveira, Suzana Lima ^a   da Roçha Ataide, Terezinha ^a   da Silva, Adriana Ximenes ^a   Cabral, Cyro Rêgo Jr ^a   de Almeida Rabello Oliveira, Marcela ^a   de Souza, Thaisa Martins Porto ^a   de Mendonca, Clara Rodrigues ^a   Lima, Carindja M Fernandes ^a   do Carmo Lins Vasconcelos Balwani, Maria ^a  

^a FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

Author keywords

High fat diet; Medium chain triacylglycerols; Metabolic effects; Trienantin

Indexed keywords

ANIMALIA; GLYCINE MAX; RATTUS; RATTUS NORVEGICUS;

EID: 77953604762     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200800298     Document Type: Article

References (44)

1. A. Y. Taha, M. A. Ryan, S. C. Cunnane: Despite transient ketosis, the classic high-fat ketogenic diet induces market changes in fatty acid metabolism in rats. Metabolism. 2005, 54, 1127-1132.
2. E. H. Kossoff: More fat and fewer seizures: Dietary therapies for epilepsy. Lancet Neurol. 2004, 3, 415-420.
3. C. Calabrese, S. Myer, S. Munson, P. Turet, T. C. Birdsall: A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs. canola oil on post-ingestion plasma triaglyceride levels in healthy men. Altern Med Rev. 1999, 4, 23-28.
4. Y. M. Liu, S. Williams, C. Basualdo-Hammond, D. Stephens, R. Curtis: A prospective study: Growth and nutritional status of children treated with the ketogenic diet. J Am Diet Assoc. 2003, 103, 707-712.
5. N. Nosaka, H. Maki, Y. Suzuki, H. Haruna, A. Ohara, M. Kasai, H. Tsuji, T. Aoyama, M. Okazaki, O. Igarashi, K. Kondo: Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb. 2003, 10, 290-298.
6. W. Guo, W. Xie, J. Han: Modulation of adipocyte lipogenesis by octanoate: Involvement of reactive oxygen species. Nutr Metab. (Lond.) 2006, 3, 30.
7. R. Curi, C. Pompéia, C.K. Miyasaka, J. Procópio: Entendendo as gorduras. Os ácidos graxos. Editora Manole, São Paulo (Brazil) 2002.
8. L. C. Nebeling, E. Lerner: Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc. 1995, 95, 693-697.
9. E. P. Vining: Clinical efficacy of the ketogenic diet. Epilepsy Res. 1999, 37, 181-190.
10. G. Coppola, P. Veggiotti, R. Cusmai, S. Bertoli, S. Cardinali, C. Dionisi-Vici, M. Elia, M. L. Lispi, C. Sarnelli, A. Tagliabue, C. Toraldo, A. Pascotto: The ketogenic diet in children, adolescents and young adults with refractory epilepsy: An Italian multicentric experience. Epilepsy Res. 2002, 48, 221-227.
11. K. H. Yeom, J. T. H. Schonewille, H. Everts, J. M. Zoet, A. C. Beyner: Impact of dietary soybean oil versus medium-chain triglycerides on plasma fatty acids in goats. Small Rumin Res. 2003, 48, 201-208.
12. F. Mochel, P. DeLonlay, G. Touati, H. Brunengraber, R. P. Kinman, D. Rabier, C. R. Roe, J. M. Saudubray: Pyruvate carboxylase deficiency: Clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab. 2005, 84, 305-312.
13. C. R. Roe, L. Sweetman, D. S. Roe, F. David, H. Brunengraber: Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic oddchain triglyceride. J Clin Invest. 2002, 110, 259-269.
14. T. R. Ataide, S. L. Oliveira, F. M. Silva, L. G. C. Vitorino Filha, M. C. N. Tavares, A. E. G. Sant'Ana: Toxicological analysis of the chronic consumption of diheptanoin and triheptanoin in rats. Int J Food Sci Technol. 2009, 44, 484-492.
15. P. G. Reeves: Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997, 127 (Suppl. 5), 838S-841S.
16. F. J. Sanchez-Muniz, S. Bastida: Do not use the Friedewald formula to calculate LDL-cholesterol in hypercholesterolaemic rats. Eur J Lipid Sci Technol. 2008, 110, 295-301.
17. R. J. Wurtman: Behavioural effects of nutrients. Lancet. 1983, 1, 1145-1147.
18. M. M. Lavau, S. A. Hashim: Effect of medium chain triglyceride on lipogenesis and body fat in the rat. J Nutr. 1978, 108, 613-620.
19. J. Han, J. A. Hamilton, J. L. Kirkland, B. E. Corkey, W. Guo: Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obes Res. 2003, 11, 734-744.
20. M. Krotkiewski: Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord. 2001, 25, 1393-1400.
21. L. Asakura, A. M. Lottenberg,M. Q. Neves, V. S. Nunes, J. C. Rocha, M. Passarelli, E. R. Nakandakare, E. C. Quintão: Dietary medium-chain triacyglycerol prevents the postprandial rise of plasma triacyglycerols but induces hypercholesterolemia in hypertriglyceridemic subjects. Am J Clin Nutr. 2000, 71, 701-705.
22. J. O. Hill, J. C. Peters, L. L. Swift, D. Yang, T. Sharp, N. Abumrad, H. L. Greene: Changes in blood lipids during six days overfeeding with medium or long chain triglycerides. J Lipid Res. 1990, 31, 407-416.
23. W. Zhou, P. Mukherjee, M. A. Kiebish, W. T. Markis, J. G. Mantis, T. N. Seyfried: The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab. (Lond.) 2007, 4, 5.
24. T. Toda, H. Oku: Effect of medium-chain fatty acids on cholesterolemia and atherosclerosis to Japanese-quails. Nutr Res. 1995, 15, 99-113.
25. N. Nosaka, M. Kasai, M. Nakamura, I. Takahashi, M. Itakura, H. Takeuchi, T. Aoyama, H. Tsuji, M. Okazaki, K. Kondo: Effects of dietary medium-chain triacyglycerols on serum lipoproteins and biochemical parameters in healthy men. Biosci Biotechnol Biochem. 2002, 66, 1713-1718.
26. T. Tholstrup, C. Ehnholm, M. Jauhiainen, M. Petersen, C. E. Høy, P. Lund, B. Sandström: Effects of medium-chain fatty acids and oleic acid on blood lipids lipoproteins, glucose, insulin, and lipid transfer protein activities. Am J Clin Nutr. 2004, 79, 564-569.
27. N. B. Cater, H. J. Heller, M. A. Denke: Comparison of the effects of medium-chain triacyglycerols, palm oil, and high oleic acid sunflower oil on plasma triacyglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr. 1997, 65, 41-45.
28. E. P. Vining, P. Pyzik, J. McGrogan, H. Hladky, A. Anand, S. Kriegler, J. M. Freeman: Growth of children on the ketogenic diet. Dev Med Child Neurol. 2002, 44, 796-802.
29. M. Kasai, H. Maki, N. Nosaka, T. Aoyama, K. Ooyama, H. Uto, M. Okazaki, O. Igarashi, K. Kondo: Effect of mediumchain triglycerides on the postprandial triglyceride concentration in healthy men. Biosci Biotechnol Biochem. 2003, 67, 46-53.
30. P. J. Randle, P. B. Garland, C. N. Hales, E. A. Newsholme: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963, 1, 785-789.
31. D. E. Kelly, M. Mokan, J. A. Simoneau, L. J. Mandarino: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest. 1993, 92, 91-98.
32. C. M. Cheng, B. Kelley, J. Wang, D. Strauss, D. A. Eagles, C. A. Bondy: A ketogenic diet increases brain insulin-like growth factor receptor and glucose transporter gene expression. Endocrinology. 2003, 144, 2676-2682.
33. V. Van Wymelbeke, J. Louis-Sylvestre, M. Fantino: Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isonergetic load of carbohydrate. Long-chain triacyglycerols, or medium-chain triacylglycerols. Am J Clin Nutr. 2001, 74, 620-630.
34. S. Kielb, H. P. Koo, D. A. Bloom, G. J. Faerber: Nephrolithiasis associated with the ketogenic diet. J Urol. 2000, 164, 464-466.
35. D. K. Groesbeck, R. M. Bluml, E. H. Kossoff: Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006, 48, 978-981.
36. A. Sampath, E. H. Kossoff, S. L. Furth, P. L. Pyzik, E. P. Vining: Kidney stones and the ketogenic diet: Risk factors and prevention. J Child Neurol. 2007, 22, 375-378.
37. D.W. Kim, H. C. Kang, J. C. Park, H. D. Kim: Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics. 2004, 114, 1627-1630.
38. I. P. Heilberg, N. Schor: Renal stone disease: Causes, evaluation and medical treatment. Arq Bras Endocrinol Metabol. 2006, 50, 823-831.
39. H. Kono, H. Fujii, M. Asakawa, M. Yamamoto, M. Matsuda, A. Maki, Y. Matsumoto: Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg. 2003, 237, 246-255.
40. P. Thavendiranathan, A. Mendonça, C. Dell, S. S. Likhodii, K. Musa, C. Iracleous, S. C. Cunnane, W. M. Burnham: The MCT ketogenic diet: Effects on animal seizure models. Exp Neurol. 2000, 161, 696-703.
41. M. J. Geelen: Medium-chain fatty acids as short-term regulators of hepatic lipogenesis. Biochem J. 1994, 302 (Pt 1), 141-146.
42. A. Koteish, A. M. Diehl: Animal models of steatosis. Semin Liver Dis. 2001, 21, 89-104.
43. A. Koteish, A. Mae Diehl: Animal models of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002, 16, 679-690.
44. E. L. Lien, F. G. Boyle, J. M. Wrenn, R. W. Perry, C. A. Thompson, J. F. Borzelleca:Comparison of AIN-76A and AIN-93 diets: A 13-week study in rats. Food Chem Toxicol. 2001, 39, 385-392.